Respiratory Research

Journal

Publication Venue For

  • Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort..  19:257. 2018
  • Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli..  19:91. 2018
  • Pectoralis muscle area and mortality in smokers without airflow obstruction..  19:62. 2018
  • Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts..  19:20. 2018
  • Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice..  18:173. 2017
  • Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)..  18:124. 2017
  • GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease..  18:42. 2017
  • Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study..  17:165. 2016
  • Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study..  17:43. 2016
  • Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS)..  17:1. 2016
  • Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study..  16:142. 2015
  • Roflumilast partially reverses smoke-induced mucociliary dysfunction..  16:135. 2015
  • Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation..  15:105. 2014
  • Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease..  15:113. 2014
  • DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease..  15:97. 2014
  • Airway wall thickness is increased in COPD patients with bronchodilator responsiveness..  15:84. 2014
  • Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene..  15:89. 2014
  • Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study..  15:52. 2014
  • Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease..  15:25. 2014
  • Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis..  15:18. 2014
  • Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials..  14:73. 2013
  • Exploring factors influencing asthma control and asthma-specific health-related quality of life among children..  14:26. 2013
  • Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study..  12:136. 2011
  • The clinical features of the overlap between COPD and asthma..  12:127. 2011
  • N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD..  10:38. 2009
  • Longitudinal association of body mass index with lung function: the CARDIA study..  9:31. 2008
  • Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration..  6:128. 2005
  • Estimation of airway obstruction using oximeter plethysmograph waveform data..  6:65. 2005
  • Electronic International Standard Serial Number (eissn)

  • 1465-993X